Haemophilus Influenzae Type b — Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants
Citation(s)
Study in Healthy Children of GSK Biologicals' DTPa-IPV/Hib-MenC-TT Vaccine, GSK2197870A, Co-administered With Prevenar™ as a Three-dose Primary Vaccination Course in Infancy Followed by a Booster Dose of Menitorix™ at 12 Months of Age